FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to immunotechniques. Method of human blood serum testing for OncoMarker MUC1 is offered for diagnostics of breast cancer (BC) by direct solid-phase bivalent immune photometric analysis using pair of homogeneous antibodies M3F1/M3B11. Formed antigen-antibody complexes are detected using Mab-peroxidase conjugate followed by introduction of stain TMB, and standard OncoMarker is human fat lactoglobule antigen MUC1. Method allows for primary diagnostics of BC stages II and III and for prediction of secondary process development (relapses), and for efficient therapy in determined diagnosis. Application of declared method allows to detect 56-63% BC patients BC by blood serum analysis.
EFFECT: possibility of primary diagnostics of BC stages II and III and prediction of secondary process development (relapses).
4 ex, 2 tbl, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR IDENTIFYING BIOLOGICAL MARKERS DETECTED IN HUMAN BIOLOGICAL MATERIALS IN VIEW OF POSSIBLE PRESENCE OF PATHOLOGICAL CONDITIONS OF THE HUMAN BODY, INCLUDING ONCOLOGICAL DISEASES, IMPLEMENTED BY MEANS OF MULTIPLEX IMMUNOENZYME SANDWICH IMMUNOASSAY | 2021 |
|
RU2779104C1 |
| STRAIN OF HYBRID CULTURED MAMMALIAN CELLS MUS MUSCULUS AS PRODUCER OF MONOCLONAL ANTIBODIES TO CONFORMATION-DEPENDENT DETERMINANTS OF TUMOR-ASSOCIATED HUMAN ANTIGEN MUC I | 2006 |
|
RU2319742C1 |
| STRAIN OF HYBRID CULTURED MAMMALIAN CELLS MUS MUSCULUS AS PRODUCER OF MONOCLONAL ANTIBODIES TO HYPOGLYCOSIDATED AND DEGLYCOSIDATED ISOFORMS OF TUMOR-ASSOCIATED HUMAN ANTIGEN MUC I | 2006 |
|
RU2319743C1 |
| MULTI-PARAMETER DIAGNOSTIC TEST SYSTEM INTENDED FOR DETECTING AND MONITORING THERAPY OF BREAST CANCER AND OVARIAN CANCER, AND ANALYSIS PROCEDURE USING SAID METHOD | 2014 |
|
RU2599890C2 |
| REAGENT KIT FOR DETECTING A MARKER OF EPITHELIAL CARCINOMAS | 2018 |
|
RU2735918C2 |
| METHOD OF SERUM DIAGNOSTICS OF PERTUSSIS | 2009 |
|
RU2424530C1 |
| STRAIN OF HYBRID CULTURED ANIMAL CELLS-PRODUCER OF RAT MONOCLONAL ANTIBODIES TO HYPOGLYCOSYLATED AND DEGLYCOSYLATED ISOFORMS OF TUMOURS ASSOCIATED WITH HUMAN MUCI ANTIGEN | 2007 |
|
RU2342428C1 |
| METHOD FOR COLORECTAL CANCER DIAGNOSIS/SCREENING BASED ON SIMULTANEOUS QUANTIFICATION OF PROTEIN NATURE TUMOUR MARKERS, GLYCANS ANTIBODIES, G, A AND M IMMUNOGLOBULINS IN HUMAN BLOOD ON BIOLOGICAL MICROCHIP | 2015 |
|
RU2625018C2 |
| NEW CANCER ANTIGEN FOR EARLY DETECTION OF CANCER, METHOD FOR OBTAINING, ISOLATION AND DETECTION THEREOF | 2020 |
|
RU2818471C2 |
| METHOD OF DETERMINING THE CONTENT OF MUC1 PROTEOLISE PRODUCTS AND DIAGNOSTIC TEST SYSTEM FOR ITS IMPLEMENTATION | 2016 |
|
RU2676258C2 |
